Seven UnitedHealth Group shareholders have asked the healthcare conglomerate to produce a report on how often its policies lead to treatment denials or delays, and the impact on patients and the economy. I’m looking for it.
of suggestionThe announcement, which could be up for a vote by UnitedHealth investors at the company’s annual meeting later this year, comes as the company faces intense public scrutiny for tactics such as pre-approvals and treatment denials. Ta. The killing of the CEO of UnitedHealth’s health insurance business in early December sparked a storm of outrage. It sparked a storm of anger, not at the alleged killer but at health insurance companies like UnitedHealth, which many blame for the industry’s dysfunction.
The shareholders who submitted the proposal are members of the Interfaith Center on Corporate Responsibility, a nonprofit coalition of more than 300 institutional investors organizing around issues such as health equity, climate change and worker rights. be. Much of the group’s research in recent years has focused on how drug company policies affect access to treatment.
This article is exclusive to STAT+ subscribers
Subscribe to STAT+ to unlock this article and get an in-depth look inside health system finances.
Already have an account? Log in
See all plans